Clinical Trials Browser

Giant Cell Tumor of Bone

NCT03449108 2025-11-21

LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas

BreastEndocrineGynecologicHead & NeckSarcoma

Bone Neoplasms, Ovarian Neoplasms, Sarcoma, Osteosarcoma, Giant Cell Tumor of Bone, Histiocytoma, Malignant Fibrous, Triple Negative Breast Neoplasms, Thyroid Carcinoma, Anaplastic

NCT03295981 2025-10-15

Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone

Phase 3 Recruiting

120 enrolled

Giant Cell Tumor of Bone

NCT04586660 2025-10-01

Study of XGEVA® (Denosumab) in Chinese Adults and Skeletally Mature Adolescents With Giant Cell Tumor of the Bone

Phase 4 Active not recruiting

36 enrolled

Giant Cell Tumor of Bone

NCT06647901 2024-10-18

Efficacy of ICG-based NIR Imaging in Intralesional Curettage of Giant Cell Tumors of Bone in Limbs: a Prospective, Single-center, Single-arm, Open Study

Phase 1/2 Recruiting

45 enrolled

Giant Cell Tumor of Bone

NCT03301857 2024-05-20

Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004

Phase 4 Completed

85 enrolled 13 charts

Giant Cell Tumor of Bone

NCT05813665 2023-04-19

A Study to Evaluate the Efficacy and Safety of Narlumosbart (JMT103) in Patients With Giant Cell Tumor of Bone

Phase 3 Not yet recruiting

146 enrolled

Giant Cell Tumor of Bone

NCT05595603 2023-03-15

Zoledronic Acid-loaded Bone Cement as a Local Adjuvant Therapy for Giant Cell Bone Tumor After Intralesional Curettage

Phase 2 Recruiting

153 enrolled

Giant Cell Tumor of Bone

NCT04255576 2022-10-14

Efficacy and Safety of JMT103 in Patients With Giant Cell Tumor of Bone

Phase 1/2 Unknown

139 enrolled

Giant Cell Tumor of Bone

NCT03620149 2021-01-06

REDUCE

Phase 2 Terminated

2 enrolled

Giant Cell Tumor of Bone

NCT00464620 2018-11-23

Trial of Dasatinib in Advanced Sarcomas

Phase 2 Completed

366 enrolled 16 charts

GastrointestinalSarcoma

Chondrosarcoma, Chordoma, Hemangiopericytoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Giant Cell Tumor of Bone, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Gastrointestinal Stromal Tumors, Solitary Fibrous Tumors

NCT03259152 2017-08-24

D-Gct

Phase 3 Unknown

30 enrolled

Giant Cell Tumor of Bone

Clinical Trials

ICG-GCTB

LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas

Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone

Study of XGEVA® (Denosumab) in Chinese Adults and Skeletally Mature Adolescents With Giant Cell Tumor of the Bone

Efficacy of ICG-based NIR Imaging in Intralesional Curettage of Giant Cell Tumors of Bone in Limbs: a Prospective, Single-center, Single-arm, Open Study

Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004

A Study to Evaluate the Efficacy and Safety of Narlumosbart (JMT103) in Patients With Giant Cell Tumor of Bone

Zoledronic Acid-loaded Bone Cement as a Local Adjuvant Therapy for Giant Cell Bone Tumor After Intralesional Curettage

Efficacy and Safety of JMT103 in Patients With Giant Cell Tumor of Bone

REDUCE

Trial of Dasatinib in Advanced Sarcomas

D-Gct